Latest Breaking News On - மேரி வர்கீஸ் பிரெஸ்த்ி - Page 1 : comparemela.com
Empowering Medical Coders With AI To Increase Efficiency And Accuracy
By Walker Bradham and Mary Varghese Presti
These days, every aspect of the drug development process is being scrutinized by pharma companies seeking to streamline their operations. Clinical trials, in particular, were a common target in 2020 as firms scrambled to find alternatives to their traditional models amidst the COVID-19 pandemic.
As anyone involved with clinical trial operations or data management can tell you, medical coding is an often-overlooked element of the process that is ripe for improvement. To understand the importance of this function, consider the example of a COVID-19 vaccine trial being paused due to patients with unexplained illnesses. “The researchers are looking for expected or unexpected reactions to a given treatment to make decisions such as halting or adjusting a trial,” explains Walker Bradham, an Offering Manager at IBM Watson Health who works extensively on IBM Clinical Develo
Walker-bradham
Mary-varghese-presti
Watson-health
Ibm
Clinical-development
Mary-varghese
Offering-manager
வாக்கர்-பிரதம்
மேரி-வர்கீஸ்-பிரெஸ்த்ி
வாட்சன்-ஆரோக்கியம்
ஐபீயெம்
மருத்துவ-வளர்ச்சி
02.17.21 Why Did Veeva Become A Public Benefit Corporation?
With the spread of SARS-CoV-2 (COVID-19) intensifying, scientists, together with pharmaceutical companies, are reinventing the approach of how to bring life-saving drugs to market. Attend this webinar to learn more about bringing life-saving drugs to market faster without impacting product quality, safety, or efficacy and the impacts and comparisons of classic platforms vs. new-generation platforms. And more!
By Ed Miseta, chief editor, Clinical Leader
On February 1, 2021, Veeva Systems officially became a Public Benefit Corporation (PBC). With this move, it becomes the first technology company supporting life sciences to transition to a PBC and it is also the first publicly traded corporation in any industry to make that move. How will the designation benefit the company?
Chris-varner
Stephanie-pyle
Daniel-eisenman
Mary-varghese-presti
Webinar-catalent
Yves-massicotte
Penelope-manasco
Michael-smyth
Lesley-freese
Lindsay-mcnair
Ropack-pharma-solutions
Industry-standard-research